Apparently karmaswimswami or KSS did not like my criticism of his post on Gumshoe, which was repeated here on HC and to which I replied. Seems I really got up his nose. Bad luck is all I can say.
His ego has gotten so big that his head has no room for memory because I am told that he now refutes ever saying that he claimed that TT-034 patients had been dosed in January 2014.
Well here is a little memory jogger:
January 10 2014 He said on Gumshoe,
"This month, 14 patients at both UCSD and Duke with genotype 1 HCV that have failed customary antiviral treatment will be dosed with TT-034."
January 30 2014 He said,
"Benitec’s first TT-034 patients have already been dosed. 28 days afer that first dose, the protocol calls for them to have repeat HCV RNA by RT-PCR done." (courtesy of Buda's post here on HC)
Seem someone is either waiting for a ddRNAi treatment for Alzheimer's or they are telling pork pies. Either way KSS, credibility zero.
- Forums
- ASX - By Stock
- BLT
- Dr. Peter French Reply to Dr. KSS Article on Benitec.
Dr. Peter French Reply to Dr. KSS Article on Benitec., page-29
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online